Home > Insider Trading > Filing (0001127602-20-008104)

Filing Details

Accession Number:: 0001127602-20-008104
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-27 14:48:44
Reporting Period:: 2020-02-26

Accepted Time:: 2020-02-27 14:48:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100682	Charles River Laboratories International Inc.	CRL	Services-Commercial Physical & Biological Research (8731)	061397316

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1650274	Ross David Smith	251 Ballardvale Street Wilmington MA 01887	Corporate Executive Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-02-26	4,188	$73.70	24,663	No	4	M	Direct
Common Stock	Disposition	2020-02-26	868	$160.45	23,795	No	4	S	Direct
Common Stock	Disposition	2020-02-26	898	$161.58	22,897	No	4	S	Direct
Common Stock	Disposition	2020-02-26	1,027	$162.27	21,870	No	4	S	Direct
Common Stock	Disposition	2020-02-26	657	$163.38	21,213	No	4	S	Direct
Common Stock	Disposition	2020-02-26	738	$164.19	20,475	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2020-02-26	4,188	$0.00	4,188	$73.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-02-26	2021-02-26	No	4	M	Direct

Footnotes

This sale occurred pursuant to a 10b5-1 Trading Plan.
This transaction was executed in multiple trades at prices ranging from $159.87 to $160.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $161.125 to $161.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $161.98 to $162.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $162.85 to $163.825. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $163.835 to $164.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.